• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subcutaneous immunoglobulin for patients with antibody deficiency.

作者信息

Helbert Matthew, Farragher Alex

机构信息

Department of Immunology, Manchester Royal Infirmary.

出版信息

Br J Hosp Med (Lond). 2007 Apr;68(4):206-10. doi: 10.12968/hmed.2007.68.4.206.

DOI:10.12968/hmed.2007.68.4.206
PMID:17465102
Abstract

This article provides an overview on the management of primary immunodeficiency, and discusses the pharmacokinetics of subcutaneous and intravenous immunoglobulin and the relationship between blood levels and therapeutic effects in both treatments. The article will further highlight both treatments' efficacy in preventing infections and the risk of systemic side effects with each treatment.

摘要

相似文献

1
Subcutaneous immunoglobulin for patients with antibody deficiency.
Br J Hosp Med (Lond). 2007 Apr;68(4):206-10. doi: 10.12968/hmed.2007.68.4.206.
2
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies.原发性抗体缺陷患者的皮下免疫球蛋白替代治疗
Lancet. 1995 Apr 1;345(8953):864. doi: 10.1016/s0140-6736(95)93002-7.
3
Pharmacoeconomics of immunoglobulins in primary immunodeficiency.原发性免疫缺陷中免疫球蛋白的药物经济学
Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):375-86. doi: 10.1586/erp.09.37.
4
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.原发性抗体缺陷患者的皮下免疫球蛋白替代治疗：安全性与成本
Lancet. 1995 Feb 11;345(8946):365-9. doi: 10.1016/s0140-6736(95)90346-1.
5
[Use of intravenous and subcutaneous human immunoglobulins].
Soins. 2019 Mar;64(833):13-18. doi: 10.1016/j.soin.2019.01.016.
6
[Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution].[家庭皮下和静脉注射免疫球蛋白替代治疗的经济学评估]
Rev Med Interne. 2006 Dec;27(12):924-6. doi: 10.1016/j.revmed.2006.08.005. Epub 2006 Sep 18.
7
Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance.从德国法定医疗保险的角度对抗体缺陷患者免疫球蛋白治疗进行药物经济学评估。
Eur J Health Econ. 2005 Mar;6(1):24-9. doi: 10.1007/s10198-004-0250-5.
8
Self-infusion of intravenous immunoglobulin by immunodeficient patients at home.
J Infect Dis. 1987 Oct;156(4):652-4. doi: 10.1093/infdis/156.4.652.
9
Subcutaneous immunoglobulin loading regimens for previously untreated patients with primary antibody deficiency.原发性抗体缺陷病初治患者的皮下免疫球蛋白负荷方案
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):146-8. doi: 10.1111/cei.12548.
10
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.静脉注射与皮下注射免疫球蛋白替代疗法的疗效和安全性比较。
J Clin Immunol. 2000 Mar;20(2):94-100. doi: 10.1023/a:1006678312925.

引用本文的文献

1
A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.一项多中心、开放性、单臂试验，旨在评估 IGSC 20%在原发性免疫缺陷患者中的疗效、药代动力学、安全性和耐受性。
J Clin Immunol. 2022 Apr;42(3):500-511. doi: 10.1007/s10875-021-01181-6. Epub 2022 Jan 1.
2
Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.皮下免疫球蛋白治疗原发性和继发性免疫缺陷：循证综述。
Drugs. 2013 Aug;73(12):1307-19. doi: 10.1007/s40265-013-0094-3.